COVID-19 pandemic and its reflection on breast cancer screening in Brazil
DOI:
https://doi.org/10.36311/jhgd.v34.15810Keywords:
Breast neoplasms, Screening programs, Public Health Policies, Health Information Systems, Covid-19Abstract
Introduction: breast cancer has been the leading cause of death among women in Brazil and worldwide. During the years of social isolation due to COVID-19, health services, including breast cancer screening, were suspended in an attempt to contain the spread of the virus, interfering with the early detection and treatment of breast cancer, effective means of reducing mortality.
Objective: to identify how the COVID-19 pandemic has interfered with the therapeutic itinerary for breast cancer in Brazilian regions.
Method: this is an observational, ecological study, carried out through secondary analysis of data available on the website of the Department of Informatics of the Unified Health System (DATASUS).
Results: information was collected from all screening bilateral mammography exams in women aged 50 to 69 years, positive cases, and therapeutic modalities from 2018 to 2022. The data showed that the pandemic impacted Brazilian regions differently, requiring different strategies and investments to ensure access to health services and minimize the impacts of the pandemic.
Conclusion: although the survey did not show statistically significant results, the southeast region stood out in the registration of cases, but shows a drop-in case registered between 2021 and 2022. On the other hand, the northern region had the lowest number of cases in all years.
Downloads
References
Sung H, Ferlay J, Siegel RL, Laversanne M, et al. GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Atlas da mortalidade. Rio de Janeiro: INCA, 2022. Base de dados. Disponível em: https://www.inca.gov.br/app/mortalidade
Instituto Nacional de Câncer José Alencar Gomes da Silva. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação. Rio de Janeiro: INCA, 2019b. Disponível em: https://www.inca.gov.br/publicacoes/livros/situacao-do-cancerde-mama-no-brasilsintese-de-dados-dos-sistemas-de-informacao
Brasil. Ministério da Saúde. Portaria de consolidação nº2, de 28 de setembro de 2017. Consolidação das normas sobre as políticas nacionais de saúde do Sistema Único de Saúde. Brasília, DF: Ministério da Saúde, 2017a. Anexos IX e XXII. Disponível em: http://bvsms.saude. gov.br/bvs/saudelegis/gm/2017/prc0002_03_10_2017.html
Instituto Nacional de Câncer José Alencar Gomes da Silva. Detecção precoce do câncer / Instituto Nacional de Câncer José Alencar Gomes da Silva. – Rio de Janeiro: INCA, 2021.
Instituto Nacional de Câncer. Diretrizes para a detecção precoce do câncer de mama no Brasil. Rio de Janeiro, 2015.
Migowski A. et al. Diretrizes para detecção precoce do câncer de mama no Brasil. II - Novas recomendações nacionais, principais evidências e controvérsias. Cadernos de Saúde Pública, Rio de Janeiro, 2018;34(6): p.74817
Lowry KP.et al. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic. Radiology, 2022;303(20):287-294.
Eijkeloom AH.; et al. Impact of the COVID-19 pandemic on the diagnosis, stage and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol,2021; 14(1):64.
Rocha AFBM, et al. COVID-19 and Breast Cancer in Brazil. International Journal of Public Health, 2023; 68(1):1605485.
Tang A. et al. Care in times of COVID-19: impact on breast cancer diagnosis and treatment in a large integrated health care system. Research in Breast Cancer Treatment, 2022;191(1):665-675.
Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nature Reviews. Clinical Oncology, 2020; 17(6):329-331.
Sprague BL, et al. Changes in mammogram use by women’s characteristics during the first 5 months of the COVID-19 pandemic. J Natl Cancer Inst. 2021; 113(9):1161-1167.
The Lancet Oncology. COVID-19: Global consequences for oncology. Lancet Oncol. 2020; 21(4):467.
Sprague BL. et al. Changes in mammogram use by women’s characteristics during the first 5 months of the COVID-19 pandemic. J Natl Cancer Inst. 2021; 113(9):1161-1167.
Rocco N. et al., The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives. The Oncologist, 2021; 26(1): e66-e77.
Al-Shamsi HO. et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncol. 2020; 25(6): e936-e945.
Harky A, Chiu CM, Yau THL, Lai SHD. Cancer Patient Care during COVID-19. Cancer Cell, 2020; 37(6):749-750.
Vanni G. et al. Advanced stages and increased need for adjuvant treatments in breast câncer patients: the effect of the year-long COVID-19 pandemic. Research in Anticancer Actions, 2021; 41(1): 2689-2696.
Schifferdecker KE, et al. Women’s considerations and experiences for breast câncer screening and surveillance during the COVID-19 pandemic in the United States: a focus group study. Preventive Medicine, 2021; 151(1):106542.
Gathani T, et al. The COVID-19 pandemic and the impact on breast cancer diagnoses: what happened in England in the first half of 2020. British Journal of Cancer, 2020; 124(1):710-712.
Gosset M, Gal J, Schiappa R, Dejode M, Fouché Y, Alazet F, et al. Impact de la pandémie de COVID-19 sur les prises em charge pour cancer du sein et gynécologique. Bulletin du Cancer, 2021;108(1):3-11.
Figueroa JD, et al. The impact of the Covid-19 pandemic on breast cancer early detection and screening. Preventive Medicine, 2021; 151(1):106585.
Eijkeloom AH et al. Consortium and the COVID and Cancer-NL Consortium. Impact of the suspension and restart of the Dutch breast cancer screening program on breast câncer incidence and stage during the COVID-19 pandemic. Preventive Medicine, 2021; 151(1):106602.
Wilke LG. et al., Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries. Annals of Surgical Oncology, 2021; 28(10):5535-5543.
Mathelin C. et al. Breast cancer management during the COVID-19 pandemic: research from the Senologic International Society. Eur J Breast Health, 2021; 17(3):188-196.
Tonneson JE, et al. Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management. Annals of Surgical Oncology, 2022; 29(4): 2231- 2239.
Rocco N, et al. The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives. The Oncologist, 2021; 26(1): e66-e77.
Romics L, et al. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland. Breast, 2021; 55(1):1-6.
Li J, Wang H, Geng C, et al. Suboptimal declines and delays in early breast câncer treatment following COVID-19 quarantine restrictions in China: a national survey of 8,397 patients in the first quarter of 2020. EClinical Medicine, 2020; 22(1): 100352.
Sattar AK, et al. Uma abordagem multidisciplinar para triagem de pacientes com doenças da mama durante a pandemia de COVID-19: experiência de um centro de atendimento terciário no mundo em desenvolvimento. Representante do Câncer, 2021; 4(1):e1309.
Brenes Sánchez JM, et al. Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy. Clinical Breast Cancer, 2021; 21(1):e128-e135.
Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nature Reviews. Clinical Oncology, 2020; 17(6):329-331.
Romics L, et al. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland. Breast, 2021; 55(1): 1-6.
Cocco D, Valente SA. Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Patients During the COVID-19 Pandemic. Annals of Surgical Oncology, 2021; 28(7):4056- 4057.
Fortunato L, et al. Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey. Clinical Breast Cancer, 2021; 21(3)0:e165-e167.
Golshan M, et al. Breast Conservation After Neoadjuvant Chemotherapy for TripleNegative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial. JAMA Surg, 2020; 155(3).
Moraes MR. Tendência temporal da realização de mastectomia e de reconstrução de mamas no Brasil no período de 2009 a 2018. Medicina-Pedra Branca, 2020.
Vanni G, et al. Advanced stages and increased need for adjuvant treatments in breast câncer patients: the effect of the year-long COVID-19 pandemic. Research in Anticancer Actions, 2021; 41(1):2689-2696.
Macinnes EG, et al. Breast Cancer Surgery During the COVID-19 Pandemic Peak in the UK: Operative Outcomes. Cureus, 2020; 12(7): e9280.
Curigliano G, et al. Recommendations for screening, prioritization, and treatment of breast cancer patients during the covid-19 pandemic. Breast, 2020; 52(1): 8-16.
Druesne-Pecollo N, et al. Excess body weight and second primary cancer risk after breast cancer: A systematic review and meta-analysis of prospective studies. Breast Cancer Research and Treatment, 2012; 135(1): 647–654.
Courtney A, et al. O estudo b-Map-C: caminhos de gerenciamento do câncer de mama durante a pandemia de covid-19. protocolo de estudo. Int J Surg Protocol, 2020; 24(1): 1-5.
Savard J, Jobin-Théberge A, Massicotte V, Banville C. How did women with breast cancer experience the first wave of the COVID-19 pandemic? A qualitative study. Supportive Care in Cancer, 2021; 29(10): 5721-5727.
Chen G, et al. Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19. Psychooncology, 2020; 29(1): 1395-1398.
Wang Y, et al. Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic. Translational Psychiatry, 2020; 10(1): 263.
Lally RM, et al. CaringGuidance after breast cancer diagnosis eHealth psychoeducational intervention to reduce early post-diagnosis distress. Supportive Care in Cancer, 2020; 28(1):2163-2174.
Sajjad M, et al. Experiências vividas de “incerteza da doença” de pacientes iranianos com câncer: um estudo hermenêutico fenomenológico. Enfermagem Oncológica, 2016;39(4):E1-E8.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Cunha UMM, Lucena KDT, Sousa LVA
This work is licensed under a Creative Commons Attribution 4.0 International License.
